Cancer
Positive pre-clinical results announced for OXi4503 in cancer models
Published in Women's Health Weekly, April 29th, 2004
Professor Klaus Edvardsen, MD, PhD, evaluated the synergistic effects of OXi4503 with standard-of-care chemotherapy drugs Carboplatin and Paclitaxel in the MDA-MB-231 human breast adenocarcinoma and the ES-2 ovarian carcinoma models grown in mice.
"At doses ranging from 10 to 50 mg/kg, OXi4503 significantly enhanced the anti-tumor effects of the chemotherapeutic agents," said Dai Chaplin, PhD, OXiGENE's chief scientific officer and head of research...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Annual screening may not be enough for women with genetic mutations - Breast Cancer
Association found between primary, contralateral breast cancers - Hormone Replacement Therapy
ERT doesn't prevent chronic disease in older women with prior hysterectomy - Lung Cancer
Tobacco use fingered as culprit in lung cancer increase in women - Patient Compliance
Women, Latinos, poor are more likely to be non-adherent HIV/AIDS patients - Abdominal Cancers
Selective radiation therapy to abdomen can preserve fertility - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
